Abstract:Multidrug resistance proteins (MRP2, ABCC2) may play a role in drug resistance in epilepsy by limiting gastrointestinal absorption and brain access of antiepileptic drugs (AEDs). We sought to investigate the effects of ABCC2 polymorphisms on plasma carbamazepine (CBZ) concentrations and pharmacoresistance in Chinese patients with epilepsy. ABCC2 rs717620, rs2273697, rs3740066 polymorphisms were genotyped by polymerase chain reaction amplification followed by restriction fragment length polymorphism analysis or direct automated DNA sequencing in 80 patients treated with CBZ monotherapy. There were no differences in CBZ maintenance doses or adjusted plasma CBZ concentrations among the ABCC2 rs717620, rs2273697 and rs3740066 genotypic groups. No associations between all the studied genotypes and haplotypes involving the three SNPs of ABCC2 and CBZ resistance were observed in this patient cohort. These results suggest that ABCC2 polymorphisms may not contribute to interindividual variabilities in CBZ daily maintenance doses, plasma concentrations, and treatment efficacy. Neurology Asia 2015; 20(3) : 221 – 227 Address correspondence to: Yingjie Guo, School of Life Sciences, Jilin University, Changchun, 130021, China. Tel: +86-431-85155316; Fax:+86-431-85155316; E-mail: guoyingjie@jlu.edu.cn INTRODUCTION Carbamazepine (CBZ) is one of the most frequently prescribed anticonvulsant drugs for the treatment of epileptic seizures. Wide variabilities of CBZ daily maintenance doses, plasma concentrations, and treatment efficacy have been observed among patients treated with this agent. There is evidence that drug efflux transporters may play a role in drug-resistant epilepsy by limiting gastrointestinal absorption and brain access of antiepileptic drugs (AEDs). Therefore, genetic variants of drug transporter genes associated with functional variations in efflux activity may influence CBZ plasma concentration and treatment efficacy. Drug transporters are members of the membrane transport protein families belonging to either ATP-binding cassette (ABC) or solutelinked carrier super family of proteins. Among them, P-glycoprotein (P-gp), encoded by ABCB1 (or MDR1), is an extensively studied drug efflux transporter in epilepsy. Although it remains equivocal whether CBZ is a substrate of P-gp, numerous studies have explored the role of ABCB1 polymorphisms on the drug response in different ethnicities. Recently, multidrug resistance proteins (MRP2, ABCC2), have been shown to mediate CBZ transport. Increased expressions of ABCC2 have been observed in brain tissues of patients with refractory epilepsy. It was hypothesized that genetic variations in the ABCC2 gene would probably affect individual drug responses to CBZ. ABCC2 rs717620, rs2273697 and rs3740066 are the major functional genetic variants, which have been characterized for their influence on the respective mRNA, protein expression, or oral clearance of drug substrates. Choi et al. showed that the combined variation of rs1885301and rs717620 decreased ABCC2 promoter activity by 39%. Laechelt et al. demonstrated both a decrease and an increase in ABCC2 expression or activity with different haplotypic combinations of rs717620, rs2273697 and rs3740066, which is supported by functional data showing these ABCC2 polymorphims affected the clearance of Neurology Asia September 2015 222 mycophenolic acid, methotrexate or irinotecan. Recently, Puranik et al. reported that the rs2273697 variant was associated with higher CBZ clearance, and adverse neurological drug reactions to CBZ, but there are some conflicting results in other studies. These conflicting results reinforce the need to check the functional significance of ABCC2 polymorphisms in different ethnic groups. The present study was performed to evaluate associations of the rs717620, rs2273697 and rs3740066 genotypes of ABCC2 and their haplotypic combinations with CBZ plasma levels and treatment efficacy in Chinese patients with epilepsy.

The Loss-of-Function ATP Binding Cassette Subfamily G Member 2 Polymorphism ABCG2 c.421C>A Reduces Lamotrigine Trough Concentrations in Adults with Epilepsy

Specific OCT1 and ABCG2 Polymorphisms Are Associated with Lamotrigine Concentrations in Chinese Patients with Epilepsy

Polymorphisms of ABCG2 , ABCB1 and HNF4α are associated with Lamotrigine trough concentrations in epilepsy patients

Effect of Genetic Polymorphisms of ABCB1, ABCG2, and SLC22A1 on the Steady-State Plasma Concentrations of Lamotrigine in Treatment-Resistant Depressed Patients Treated With Lamotrigine Augmentation Therapy

Pharmacokinetics of lamotrigine and its metabolite N-2-glucuronide: Influence of polymorphism of UDP-glucuronosyltransferases and drug transporters

The antiepileptic drug lamotrigine is a substrate of mouse and human breast cancer resistance protein (ABCG2)

Influence of UGT2B7, UGT1A4 and ABCG2 Polymorphisms on the Pharmacokinetics and Therapeutic Efficacy of Lamotrigine in Patients with Epilepsy

Impact of ABCB1 Polymorphism on Levetiracetam Serum Concentrations in Epileptic Uygur Children in China

The Effects of ABCC2 G1249A Polymorphism on the Risk of Resistance to Antiepileptic Drugs: a Meta-Analysis of the Literature.

Effects of UGT1A4 genetic polymorphisms on serum lamotrigine concentrations in Chinese children with epilepsy.

Influence of genetic variants and antiepileptic drug co-treatment on lamotrigine plasma concentration in Mexican Mestizo patients with epilepsy

Influence of transporter genetic polymorphisms on valproic acid blood concentration and clinical efficacy of epilepsy patients

ABCC2 polymorphisms and haplotype are associated with drug resistance in Chinese epileptic patients.

Functional analysis of nonsynonymous single nucleotide polymorphisms of multidrug resistance-associated protein 2 (ABCC2)

ABCC2 rs2273697 is associated with valproic acid concentrations in patients with epilepsy on valproic acid monotherapy.

Effects of UGT2B7 Genetic Polymorphisms on Serum Concentrations of Valproic Acid in Chinese Children with Epilepsy Comedicated with Lamotrigine.

Relationship between ABCB1 3435TT genotype and antiepileptic drugs resistance in Epilepsy: updated systematic review and meta-analysis

Correlation of the UGT1A4 gene polymorphism with serum concentration and therapeutic efficacy of lamotrigine in Han Chinese of Northern China

Influence of the UGT2B7 -161C>T polymorphism on the population pharmacokinetics of lamotrigine in Thai patients

Lack of association between ABCC 2 polymorphisms and plasma carbamazepine concentrations or pharmacoresistance in Chinese patients with epilepsy

ABCB1 c.3435C > T and EPHX1 c.416A > G polymorphisms influence plasma carbamazepine concentration, metabolism, and pharmacoresistance in epileptic patients